OTC derivatives still main challenge

Morse's Miriam Edelman who conducted the survey, says 95% of respondents expect changes to their operating model precipitated primarily by the introduction of new instruments and new products; of these, 30% believe that the operating model will be a constraint on achieving business objectives.

Interestingly, Edelman reports that traditional asset managers seemed as affected by the anticipated focus on exotic instruments as their alternative counterparts - hedge funds and funds of funds.

"We

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: